Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

DEXTROSE INJECTION

Active
SPE2DP-26-T-4393Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100146 BOX 1, FPO, AP, 96669, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
JAMES FOGGIE
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
DEXTROSE INJECTION
DEXTROSE INJECTION 5%, USP, 1000 ML, 12S
RX ONLY.CONCENTRATION: 5%. TOTAL CONTENT: 1,000 ML STERILE AND
NONPYROGENIC.INTENDED FOR INTRAVENOUS ADMINISTRATION.SUPPLIED IN
SINGLE-DOSE CONTAINERS (BAGS).ROUTE: INTRAVENOUS DOSE FORM: INTRAVENOUS
SOLUTION STRENGTH: 5 %. LATEX-FREE. EACH 1,000 ML CONTAINS HYDROUS
DEXTROSE USP 5 GRAMS AND WATER FOR INJECTION USP.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
THE UNIT OF ISSUE IS A PACKAGE CONTAINING 12 EACH (PLASTIC BAGS). STORE
AT 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE].
PROTECT FROM FREEZING AND AVOID EXCESS HEAT.
INCLUDE ZX001 OBJECT TEXT ID ST
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N L5100 B. BRAUN MEDICAL INC 11171 P/N NDC00264-7510-00 ICU MEDICAL, INC. 1RNZ0 P/N NDC00990-7922-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017682478 0001 PG 1.000
SPE2DP-26-T-4393
SECTION B
PR: 7017682478 PRLI: 0001 CONT’D
NSN/MATERIAL:6505013306252
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21605
USS JEFFERSON CITY SSN 759
UNIT 100146 BOX 1
FPO AP 96669
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21605
USS JEFFERSON CITY SSN 759
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R2160561853252
RDD: 777
PROJ: JK5 TP 2
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: E9B ADV: 2A FC: M7
Need Ship Date:00/00/0000 Original Required Delivery Date:08/03/2026
SPE2DP-26-T-4393
SECTION B
PR: 7017682478 PRLI: 0001 CONT’D

DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7017682435 0001 PG 1.000
NSN/MATERIAL:6505013306252
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT PKGING DATA-QUP:001 IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313, PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025. IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
V27153
USS DELAWARE (SSN 791)
COMMANDING OFFICER
UNIT 100339 BOX 1
SPE2DP-26-T-4393
SECTION B
PR: 7017682435 PRLI: 0001 CONT’D
FPO AE 09583
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
V27153
USS DELAWARE (SSN 791)
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) V2715362033075
RDD: 777
PROJ: JP5 TP 1
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A4A DIST: E9B ADV: 2A FC: CC
Need Ship Date:00/00/0000 Original Required Delivery Date:08/03/2026
SPE2DP-26-T-4393 NSN/Part Number: 6505-01-330-6252 Quantity: 1 PG Purchase Request: 7017682435QTY: 1 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
WATER FOR INJECTION, ST
Solicitation # SPE2DP-26-T-4380
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMI
Solicitation # SPE2DP-26-T-4394
ERYTHROMYCIN OPHTHALMIC OINTMENT USP is a sterile, topical ointment containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, intended for ophthalmic use only. Each unit is packaged as a single-dose tube containing 3.5 grams of ointment, with 24 tubes per package, defined as the unit of issue. The product must have a minimum of 31 months of remaining shelf life upon receipt by the first government activity, as its total shelf life is 36 months and is non-extendable. Storage requirements mandate controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must comply with DLA’s Master List of Technical and Quality Requirements. The ointment is regulated by the FDA and must be marked and shipped in accordance with commercial packaging standards, specifically ASTM D3951 if not classified as hazardous under FED-STD-313; however, DLA requirements take precedence over all other standards. Each shipment must be delivered FOB destination within five days, using the fastest traceable means, excluding parcel post, to the specified delivery point at Fort Lewis, WA. The product is identified by NSN 6505-01-189-7090, with a single purchase order quantity of one package, and the manufacturer is PADAGIS US LLC under NDC 00574-4024-39.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LAC
Solicitation # SPE2DP-26-T-4395
RINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4395 with a total order of 7 packing groups, equivalent to 84 individual units. The product is manufactured by B. Braun Medical Inc. with NDC 00264-7750-00 and is subject to FDA regulation. Packaging must comply strictly with Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Each unit must be sealed and packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the specified destination, which is FPO AP 96675. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure up to 40°C permitted. Packaging must adhere to DLA’s RP001 requirements and the latest DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. No hazard classification applies under FED-STD-313, so commercial packaging per ASTM D3951 is acceptable but subordinate to DLA standards. Delivery is required within 20 days of contract award, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is packing group (PG), with each PG containing 12 units. All markings, labeling, and palletization must conform to specified DLA and federal standards, and shipping instructions must follow DLAD Proc Note C19 and C20. The solicitation closed on August 5, 2026, with an original required delivery date of August 3, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANS
Solicitation # SPE2DP-26-T-4384
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR IRRIGATION, S
Solicitation # SPE2DP-26-T-4383
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE TOP
Solicitation # SPE2DP-26-T-4386
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DOXYCYCLINE HYCLATE
Solicitation # SPE2DP-26-T-4150
Doxycycline Hyclate Tablets, USP equivalent to 100 mg of doxycycline, are supplied in film-coated form as unit packs of 100 tablets per bottle, with the unit of issue defined as a bottle (BT). The contract mandates strict adherence to Medical Marking Standard No. 1A dated February 4, 2013, superseding all references to MIL-STD-129, and requires each unit to be sealed in a container that protects against damage and breakage, while exterior shipping containers must ensure safe, cost-effective delivery by common carriers to the designated destination. All packaging and labeling must conform to DLA’s Technical and Quality Requirements, with hazardous material handling governed by FED-STD-313 and ASTM D3951 only if the item is not classified as hazardous, and DLA’s standards take precedence over commercial standards. The product has a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 20 to 25°C (68 to 77°F), protected from light and moisture. The item is regulated by the FDA, and buyers must submit a referral through EBS to confirm bidder and manufacturer details, including NDC62135-0626-01. The total quantity ordered is eight bottles (8 BT), with delivery required within 20 days FOB destination to Fort Bragg, North Carolina, using traceable shipping methods and prohibiting parcel post. The contract prohibits any variance in quantity, and inspection and acceptance occur at the destination. The shipment must be palletized per RP001 requirements and marked with the specified government identifiers, including the NSN 6505016003042 and project code TP 3, with the supplier identified as CHARTWELL RX LLC.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 4 days
View Details
NAICS: 325412
New
DIBBS
ISOPROPYL ALCOHOL
Solicitation # SPE2DP-26-T-4385
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, U
Solicitation # SPE2DP-26-T-4391
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
Federal
6505--Ticagrelor Tablets
Solicitation # 36E79726R0028
The Department of Veterans Affairs through its National Acquisition Center is preparing to issue an unrestricted solicitation for Ticagrelor Tablets under solicitation number 36E79726R0028, targeting supply to VA facilities including Consolidated Mail Order Pharmacies and State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is divided into two mutually exclusive groups: Group I includes both 60-count bottles and bulk packaging options of 500 or 1,000 tablets per bottle for both 60mg and 90mg strengths, while Group II includes only 60-count bottles for the same strengths. Offerors must submit complete proposals for one group only, and award will go to the lowest-priced technically acceptable bid based on total evaluated price. The contract has a base term of one year with four optional one-year extensions, and product distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. All offered products must bear the offeror’s unique NDC number and be labeled exclusively with that label, with no over-labelling permitted. VA labels must be capable of adhering securely on top of the contractor’s label. Packaging requirements are strict: unit-of-use bottles must have safety caps with deshellable or convertible features, meet minimum size specifications including 120cc capacity and 5.75-inch circumference, fit a label measuring 5.25 x 2 inches with an additional 0.5 inch for barcodes and expiration details, and feature a cylindrical body. Total annual estimated demand is approximately 21,137 bottles of 60mg 60-count, 141,992 bottles of 90mg 60-count for Group I combined with either 500 or 1,000 tablet bulk options, and for Group II, approximately 52,237 and 205,992 bottles of 60mg and 90mg 60-count respectively. The solicitation will be released electronically on or about August 18, 2026, with a proposed closing date of September 1, 2026, under NAICS code 325412. All information is accessible only through SAM.gov, and inquiries must be directed via email to Kenneth Lay. No paper copies will be provided.
Nac Pharmaceuticals (36E797)

POSTED

about 21 hours ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
International
ACAN tecovirimat
Solicitation # WS5801165980
The Government of Canada, through the Department of Public Works and Government Services, has issued a solicitation for the procurement of tecovirimat under reference number WS5801165980, posted on July 30, 2026, with responses due by August 18, 2026. This federal opportunity is open to qualified suppliers and is intended for delivery within Canada, with no specific set aside or NAICS code identified. The contract is managed by the Contracting Authority, Anja Ramenason of SPAC/PSPC, who can be contacted via email at anja.ramenason@tpsgc-pwgsc.gc.ca for inquiries or additional information regarding the procurement process. The solicitation seeks to secure tecovirimat, an antiviral drug likely intended for national preparedness or public health use, under a federal acquisition framework. All responses must adhere to the specified timeline, and potential offerors are encouraged to review the full tender details via the official Canada Buys portal link provided. Performance of the contract is expected to occur across Canada without a designated local address, reflecting a nationwide scope of delivery and distribution. No physical office address is listed for the contracting office, indicating a centralized federal procurement structure.
Department of Public Works and Government Services

POSTED

1 day ago

DEADLINE

in 18 days
View Details
NAICS: 325412
New
DIBBS
Pharmaceutical Tablet Supply – Sumatriptan Succinate 25mgThe contract entails the manufacture and supply of 54,000 units of Sumatriptan Succinate 25mg film-coated tablets intended for the acute treatment of migraines, with strict adherence to current Good Manufacturing Practices (cGMP) requirements to ensure product quality, safety, and consistency. The manufacturing process and final product must comply with controlled storage conditions to maintain stability and efficacy throughout the supply chain, reflecting the sensitive nature of pharmaceutical therapeutics. The procurement is structured as a subcontract under the NAICS code 325412, which designates pharmaceutical preparation manufacturing, and is managed by the Department of Defense through its Medical Supply Chain Pharm FSA agency, with performance required at Fort Bliss, Texas, 79918-2527. The solicitation was posted on July 29, 2026, with a response deadline of August 4, 2026, indicating a tight turn-around for qualified suppliers to submit proposals. The contract is not subject to any set-aside provisions and is publicly accessible via the DIBBS platform, suggesting a competitive bidding process open to eligible contractors capable of meeting federal pharmaceutical standards. Compliance with all regulatory, packaging, labeling, and documentation requirements for defense-related medical supplies will be mandatory, and delivery timelines will likely be tied to operational readiness needs of the military healthcare system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325620
New
DIBBS
SUNSCREEN AND INSECT R
Solicitation # SPE2DP-26-T-4381
Toilet Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
MICONAZOLE NITRATE POW
Solicitation # SPE2DP-26-T-4382
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOL
Solicitation # SPE2DP-26-T-4388
Medicinal and Botanical Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details